Podcasts about ncri cancer conference

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Matthew Ellis at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about the future of proteomics and breast cancer research.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Michael Douek at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about novel techniques for breast surgery and reconstruction.

At the beginning of November, Kat went up to Liverpool for the annual NCRI Cancer Conference, bringing together scientists, doctors, nurses, patients and more from the UK and around the world to talk about the latest progress, ideas and issues in cancer research. On the first night, the charity Breast Cancer Now hosted a heated debate discussing whether after spending so much money investigating the causes of breast cancer as well as treating it, it's now time to focus efforts on preventing the disease in the first place. Sarah Hazell, Senior Research Manager at Breast Cancer Now, gave Kat a... Like this podcast? Please help us by supporting the Naked Scientists

At the beginning of November, Kat went up to Liverpool for the annual NCRI Cancer Conference, bringing together scientists, doctors, nurses, patients and more from the UK and around the world to talk about the latest progress, ideas and issues in cancer research. On the first night, the charity Breast Cancer Now hosted a heated debate discussing whether after spending so much money investigating the causes of breast cancer as well as treating it, it's now time to focus efforts on preventing the disease in the first place. Sarah Hazell, Senior Research Manager at Breast Cancer Now, gave Kat a... Like this podcast? Please help us by supporting the Naked Scientists

E-cigarettes seem to be everywhere nowadays. Invented by a Chinese pharmacist and patented in 2004, they first went on sale in 2010 and are now the most popular way to quit smoking in the UK. But although there's no smoke, there's certainly a fire of controversy around e-cigs, as Kat Arney found out when she spoke to Linda Bauld, professor of health policy at the University of Stirling, who chaired a panel discussion about e-cigarettes at the NCRI Cancer Conference. Like this podcast? Please help us by supporting the Naked Scientists

E-cigarettes seem to be everywhere nowadays. Invented by a Chinese pharmacist and patented in 2004, they first went on sale in 2010 and are now the most popular way to quit smoking in the UK. But although there's no smoke, there's certainly a fire of controversy around e-cigs, as Kat Arney found out when she spoke to Linda Bauld, professor of health policy at the University of Stirling, who chaired a panel discussion about e-cigarettes at the NCRI Cancer Conference. Like this podcast? Please help us by supporting the Naked Scientists

We’re reporting back from the 10th NCRI cancer conference, with a look at communicating cancer risks and a lifetime in research for scientist Ron Laskey.

Dr Gerard Evan talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about methods for discovering new targets for treating cancer and the continuing move towards a more personalised approach to treatment.

Dr Robert Thomas talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about a polyphenol food supplement that has been shown to slow the spread of prostate cancer. Polyphenol rich foods such as pomegranate, green tea, broccoli and turmeric have demonstrated anti-neoplastic effects in cell lines and animal models, including anti-angiogenesis, pro-apoptotic and reduced proliferation. Some have been investigated in small phase II studies. This study found a statistically significant, favourable effect on the percentage rise in PSA in this cohort of men with prostate cancer. Future trials will look at the longer term clinical effects and the benefits for men receiving ADT.

Dr Ruth Swann talks to ecancer at the 2013 NCRI Cancer Conference about breast cancer survival rates and the largest prospective observational study that examined the relationship between diet and lifestyle and breast cancer recurrence and survival rates of patients in the UK. The DietCompLyf study showed a significant inverse association between pre-diagnosis phytoestrogen consumption and possession of breast cancer risk factors. The data from the study will provide the necessary evidence base on which to test dietary and lifestyle recommendations for breast cancer patients, the overall aim of which is to reduce breast cancer recurrence rates.

Dr Andy Hall talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about the development of biobanks and collection of primary material in rare tumours. Dr Hall discusses heterogeneous tumours and the importance of access to primary material. With this access there can be a greater understanding of the tumour's biology, mutations and potential targets and biomarkers.

Dr Chris Gallagher talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about the PETROC study. The trial is a meta analysis of phase III trials of post operative intraperitoneal chemotherapy in epithelial ovarian cancer, fallopian tube and primary peritoneal cancer. In the 853 patients that participated, with 6 years follow-up, there was a reduction of 16% in risk of progression, 17% in risk of death, and increased median progression free (20 to 25 months),and overall (51 to 62 months )survival. PETROC/OV21 is designed to investigate women not able to be optimally debulked at primary surgery who have had primary IV chemotherapy and optimal interval debulking followed by IVor IP treatment, with dose paclitaxel plus carboplatinor cisplatin. The study reached the conclusion that intraperitoneal chemotherapy after interval debulking surgery is feasible and safe.

Dr Daniel Rea talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about the aTTom study. In patients with early breast cancer, tamoxifen was given for 5 years after surgery for ER-positive early breast cancer. This reduced recurrence and breast cancer mortality and was more effective than treatment for shorter durations. It has been uncertain what advantage there may be to extending tamoxifen treatment to 10 years. aTTom confirmed findings of the complementary International ATLAS study that, continuing tamoxifen to year 10 rather than just to year 5 produces further reductions in recurrence and breast cancer deaths. The proportional reduction in recurrence was unaffected by age or nodal status. Benefits from continuing tamoxifen treatment beyond year 5 emerge only after 7 years from start of treatment for recurrence and 10 years for mortality.

Dr Bernd Pichler talks to ecancer at the 2013 NCRI Cancer Conference about combination of PET/MRI, which allows for molecular and functional imaging and information to be gather analysed together.

Dr Ellen Copson talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about the rising rates of obesity in patients with early breast cancer. Previous studies have shown that this leads to a poorer prognosis than non-obese patients and that host factors, tumour pathology and treatment issues have been suggested as possible factors. The study concluded that obesity at diagnosis is associated with inferior survival in young breast cancer patients. The data confirms that obesity is associated with biologically adverse tumours and more obese patients receive sub-optimal chemotherapy than healthy weight patients.

Dr Lisa Coussens talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about inflammation and cancer and how this can be used in the tumour microenvironment. By studying transgenic mouse models of skin, lung, breast and pancreas cancer development, Dr Coussens lab found that adaptive leukocytes differentially regulate myeloid cell recruitment, activation, and behaviour, by organ-dependent mechanisms. This has been translated into a recent clinical trial involving triple negative breast cancer.

From detecting tumour DNA in our bloodstreams to making cancer cells stand out in an MRI scan, this week, coinciding with the NCRI Cancer Conference, we explore how best ways to detect cancer and monitor tumours during treatment. Plus, in the news, what a dog's wagging tail can tell you about its mood, the chemistry behind fireworks, how wind farms could be made up to 30% more efficient just by moving the turbines around, and the electronic blood that could help to shrink supercomputers...

From detecting tumour DNA in our bloodstreams to making cancer cells stand out in an MRI scan, this week, coinciding with the NCRI Cancer Conference, we explore how best ways to detect cancer and monitor tumours during treatment. Plus, in the news, what a dog's wagging tail can tell you about its mood, the chemistry behind fireworks, how wind farms could be made up to 30% more efficient just by moving the turbines around, and the electronic blood that could help to shrink supercomputers... Like this podcast? Please help us by supporting the Naked Scientists

From detecting tumour DNA in our bloodstreams to making cancer cells stand out in an MRI scan, this week, coinciding with the NCRI Cancer Conference, we explore how best ways to detect cancer and monitor tumours during treatment. Plus, in the news, what a dog's wagging tail can tell you about its mood, the chemistry behind fireworks, how wind farms could be made up to 30% more efficient just by moving the turbines around, and the electronic blood that could help to shrink supercomputers... Like this podcast? Please help us by supporting the Naked Scientists

This week Kat Arney joins us live from the National Cancer Research Institute's conference in Liverpool. We find out how mistakes in cell signalling can cause cancers and why DNA repair pathways offer targets to treat tumours. Also, we explore the latest developments in cancer imaging, including new techniques that allow us to track chemical reactions happening inside the body. In the news, why you need to remove genes to repair nerves, and how clearing out old cells can prevent diseases of old age!

This week Kat Arney joins us live from the National Cancer Research Institute's conference in Liverpool. We find out how mistakes in cell signalling can cause cancers and why DNA repair pathways offer targets to treat tumours. Also, we explore the latest developments in cancer imaging, including new techniques that allow us to track chemical reactions happening inside the body. In the news, why you need to remove genes to repair nerves, and how clearing out old cells can prevent diseases of old age! Like this podcast? Please help us by supporting the Naked Scientists

This week Kat Arney joins us live from the National Cancer Research Institute's conference in Liverpool. We find out how mistakes in cell signalling can cause cancers and why DNA repair pathways offer targets to treat tumours. Also, we explore the latest developments in cancer imaging, including new techniques that allow us to track chemical reactions happening inside the body. In the news, why you need to remove genes to repair nerves, and how clearing out old cells can prevent diseases of old age! Like this podcast? Please help us by supporting the Naked Scientists

London School of Hygiene and Tropical Medicine Audio News October 15th, 2008 Global Handwashing Day! Sex and Health More Prisoners: More TB How to Survive Cancer Global Handwashing Day is October 15th, 2008: an opportunity to remind everybody that millions of lives, especially children's lives, can be saved by avoiding diarrhoea and other diseases spread when mothers, fathers, family members and friends fail to wash their hands with both soap and water. Derek Thorne hears from Val Curtis and Robert Aunger at the London School who are spearheading initiatives all over the world to reduce this loss of life by persuading people to get into the habit of washing their hands after using the toilet. PPeter Goodwin learns from Kaye Wellings of the School about the latest phase of her massive study of sexual attitudes, behaviour and health which for the first time are looking at over 60s, and also at positive, as well as negative sexual health outcomes. Also: Martin McKee talks about the way TB has spread in the community at large as prison populations have increased in countries of the former Soviet Union. And Michel Coleman discusses with Peter Goodwin (during the NCRI Cancer Conference in Birmingham) his data showing that organisation and resources in cancer care are more significant determinants of survival than specific drugs used on patients.